{
    "2020-12-08": [
        [
            {
                "time": "",
                "original_text": "康泰生物现4笔大宗交易，共成交10,510.18万元",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年度投资策略：需求无止境 供给共繁荣",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "需求",
                        "供给"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020年12月投资月报：医药反弹持续性如何？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资月报",
                        "反弹",
                        "持续性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医药板块回暖 估值溢价已回到历史中枢水平",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "板块回暖",
                        "估值溢价",
                        "历史中枢"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物板块涨幅居前，10家公司获机构“叩门”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "涨幅",
                        "机构",
                        "叩门"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：医药板块整体反弹 持续推荐三条主线",
                "features": {
                    "keywords": [
                        "医药行业",
                        "板块反弹",
                        "推荐",
                        "主线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国君医药 | 2021年度策略：需求无止境，供给共繁荣",
                "features": {
                    "keywords": [
                        "国君医药",
                        "年度策略",
                        "需求",
                        "供给"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华泰柏瑞2医药主题基金11月跌超9% “菜鸟”接手迎震荡",
                "features": {
                    "keywords": [
                        "华泰柏瑞",
                        "医药主题基金",
                        "下跌",
                        "菜鸟",
                        "接手",
                        "震荡"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物71亿隐秘野心，李云春为何弃泽润如鸡肋？",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "隐秘野心",
                        "李云春",
                        "泽润",
                        "鸡肋"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}